International Journal of Clinical Pharmacy

Article	Citations
ESCP International Workshop: Pharmacotherapy challenges in the developing years: from conception to adolescence 24–25 April 2024, Bratislava, Slovakia	71
Comment on: “whether temporal discounting is domain‑specific between health outcomes and money—a systematic review and meta‑analysis”	59
Implementation status of safety measures to prevent errors with non-oncologic methotrexate: surveys in community and hospital pharmacies	45
Characterising pharmacists’ interventions in chronic non-cancer pain care: a scoping review	42
Parents’ perspectives towards paediatric confectionary masked medications: a qualitative study	37
Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units	35
A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country	32
Medication regimen complexity index and rehabilitation outcomes in post-acute hip fracture patients study: a retrospective study	30
Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013–2020	30
Non-cardiovascular medication and readmission for heart failure: an observational cohort study	30
Global trends in pharmacovigilance-related events: a 30-year analysis from the 2019 global burden of disease study	28
Attitudes of non-participating general practitioners and community pharmacists towards interprofessional medication management in primary care: an interview study	28
Efficacy and safety of metformin compared to insulin in gestational diabetes: a systematic review and meta-analysis of Chinese randomized controlled trials	28
Cost-effectiveness analysis of fruquintinib in Chinese patients with refractory metastatic colorectal cancer	27
Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children	27
Bacillus coagulans TBC169 probiotics for intestinal function recovery after gynecological open surgery: a randomized, double-blind, placebo-controlled trial	27
Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study	25
Response to comment on 'Perioperative esketamine combined with butorphanol versus butorphanol alone for pain management following video-assisted lobectomy: a randomized controlled trial'	25
Impact of intra-patient variability of tacrolimus on allograft function and CD4 + /CD8 + ratio in kidney transplant recipients: a retrospective single-center study	23
A systematic review of quantitative studies exploring staff views on antipsychotic use in residents with dementia in care homes	23
Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis	22
Clinical impact of an individualised clinical pharmacy programme into the memory care pathway of older people: an observational study	22
Ethical conflicts in patient care situations of community pharmacists: a cross-sectional online survey	21
Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years	21
Comparing patient reported and medical record data of adverse drug reactions to anti-seizure drugs	21

Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer	21
Reliability and validity testing of the medicines related - consultation assessment tool for assessing pharmacists’ consultations	20
Correlation between the prognostic nutritional index and outcomes in older patients aged ≥ 60 years with chronic heart failure	20
Conversational agents for pharmaceutical use: insights from the eCCo database	19
Sedative co-medication patterns across frailty states in people with HIV: a network-based study	19
Environmental scan of current strategies to decrease sedative-hypnotic drug use and promote sleep in hospital patients	18
Effects of children’s criteria for identifying potentially inappropriate prescribing on prescription review by pharmacists: a before-after study	18
Association of opioid fills with centers for disease control and prevention opioid guidelines and payer coverage policies: physician, insurance and geographic factors	17
Medication errors in emergency departments: a systematic review and meta-analysis of prevalence and severity	17
Correction to: 49th ESCP virtual symposium on clinical pharmacy 19.10.2021–21.10.2021 Clinical pharmacy, working collaboratively in mental health care	17
The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis	17
Fluoropyridmidine use and hypertriglyceridemia among Japanese patients: analysis of adverse event database	17
Critical care pharmacy service provision and workforce in adult extracorporeal membrane oxygenation centres: a multicentre cross-sectional survey	16
How to manage the dose of drugs in cancer patients with acute kidney injury, practical recommendations	16
Evaluation of osimertinib for advanced non-small cell lung cancer with leptomeningeal metastases: a cost-effectiveness and budget impact analysis	16
Pharmacist-led deprescribing of cardiovascular and diabetes medication within a clinical medication review: the LeMON study (Less Medicines in Older Patients in the Netherlands), a cluster randomized	15
Discrepancies in patients' medication lists from pharmacies in Sweden: an interview study before the implementation of the Swedish National Medication List	15
Liver injury associated with endothelin receptor antagonists: a pharmacovigilance study based on FDA adverse event reporting system data	15
Detection and management of pill swallowing difficulties: a community pharmacy-based observational study	15
Appropriateness of intravenous fluid prescriptions in hospitalised patients: a point prevalence study	14
Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study	14
Translation and validation of the CLEO tool in Vietnamese to assess the significance of pharmacist interventions	14
Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system	14
Medication supply at hospital discharge via community pharmacy: a quality improvement study	13
A case–control study on the clinical characteristics of granisetron-related arrhythmias and the development of a predictive nomogram	13
Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective study	13
Prolonged oxycodone use and potential risk factors in postoperative patients: a case control study	13
Novel opportunities for clinical pharmacy research: development of a machine learning model to identify medication related causes of delirium in different patient groups	13
How to write a successful grant application: guidance provided by the European Society of Clinical Pharmacy	13
Cost-effectiveness of toripalimab plus chemotherapy for advanced esophageal squamous cell carcinoma	12
Developing a machine learning model for predicting venlafaxine active moiety concentration: a retrospective study using real-world evidence	12
An umbrella review of the diagnostic value of next-generation sequencing in infectious diseases	12
Correction to: 50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care	12
A machine learning model exploring the relationship between chronic medication and COVID-19 clinical outcomes	12
Potentially inappropriate prescribing in a falls clinic using the STOPP and START criteria	12
Barriers to person-centered service design in pharmacy practice: examples, lessons, and potential solutions	12
Pharmacist-driven antimicrobial stewardship interventions in patients with COVID-19: a scoping review	11
Application of a screening tool to understand the medication habits of patients with swallowing difficulty: a prospective observational study	11
Impact of a clinical pharmacist on medication safety in mental health Hospital-in-the-Home: a retrospective analysis	11
Valproic acid for agitation in the intensive care unit: an observational study of psychiatric consults	11
Drivers of engagement in virtual communities of practice: a qualitative study of Australian pharmacists’ perceptions and experiences	11
Risk factors for opioid toxicity requiring naloxone rescue in adults: a case-control study	11
What do emergency department pharmacist practitioners know and understand about patient safeguarding? A qualitative study	11
Comment on “Association of polypharmacy with clinical outcomes and healthcare utilization in older adults with cardiometabolic diseases: a retrospective cohort study”	11
Cardiometabolic risk in people under 40 years with severe mental illness: reading between the guidelines	11
Opinions and experiences on the provision of care to people with mental illnesses: a qualitative study with Doctor of Pharmacy graduates after a rotation in psychiatry	10
Complementary and alternative medicine use in self-management of diabetes: A qualitative study of patient and user conversations in online forums	10
Cost-effectiveness of miglustat versus symptomatic therapy of Niemann–Pick disease type C	10
Predicting delirium in older non-intensive care unit inpatients: development and validation of the DELIrium risK Tool (DELIKT)	10
Anticholinergic burden and health-related quality of life among adult patients in a resource-limited setting: a cross-sectional study	10

Artificial intelligence in academic writing and clinical pharmacy education: consequences and opportunities	10
Comment on “The efficacy of zuranolone versus placebo in postpartum depression and major depressive disorder: a systematic review and meta-analysis”	10
Embedding cultural competency and cultural humility in undergraduate pharmacist initial education and training: a qualitative exploration of pharmacy student perspectives	10
Economic evaluation of camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma in the United States and China	10
Prevalence and trends in polypharmacy and excessive polypharmacy: a retrospective national database analysis (2012–2021)	10
Exploring the suitability of a ward-based clinical pharmacy activity collection tool for ambulatory care practice: a mixed-methods study	10
SGLT2 inhibitors associated pancreatitis: signal identification through disproportionality analysis of spontaneous reports and review of case reports	9
Clinical Pharmacist and Clinical Nurse Specialist led medicine optimisation and medication adherence via eArly identifiCation advanCed gEriatric aSsesSment (ACCESS) tool in Senior Adult Oncology Progr	9
Impact of artificial intelligence on the academic performance and test anxiety of pharmacy students in objective structured clinical examination: a randomized controlled trial	9
Preliminary feasibility assessment of a targeted, pharmacist-led intervention for older adults with polypharmacy: a mixed-methods study	9
Classification of patient characteristics associated with reported adverse drug events to neuraminidase inhibitors: an applicability study of latent class analysis in pharmacovigilance	9
Building an effective medicines optimisation model: a health system approach	9
Evaluating an integrated clinical pharmacist model in a geriatric day hospital: a prospective single-centre observational study	9
Communication issues between pharmacists and d/Deaf people: a qualitative study in Thailand	9
Exploring the time required by pharmacists to prepare discharge medicine lists: a time-and-motion study	9
Prescribing at 95 years of age: cross-sectional findings from the Newcastle 85+ study	9
Factors associated with Turkish pharmacists’ intention to receive COVID-19 vaccine: an observational study	9
Real-world safety of maribavir: a retrospective study based on signal detection in the FDA adverse event reporting system	9
A real-world pharmacovigilance study of belzutifan in renal cell carcinoma and von Hippel-Lindau disease: insights from the FDA adverse event reporting system database	9
Potential drug-drug interactions of immunosuppressants in kidney transplant recipients: comparison of drug interaction resources	9
Addressing the second victim phenomenon among community pharmacists and its impact on clinical pharmacy practice: a consensus study	9
A cost–benefit analysis of hospital-wide medication reviews: a period prevalence study	9
A quality improvement study on the effect of electronic transmission of a basic discharge medication report on medication discrepancies in patients discharged from the hospital	9
A consolidated framework for implementation research (CFIR) guided exploration of key informant perspectives on establishing a pharmacist-led anticoagulation service in primary care: a qualitative stu	8
Development of a robust predictive model for neutropenia after esophageal cancer chemotherapy using GLMMLasso	8
A qualitative evaluation of barriers and facilitators to a large-scale antithrombotic stewardship intervention in the United States Veterans Healthcare system	8
A retrospective cohort study of the effect of rapid versus delayed-result procalcitonin testing on antibiotic use at a community hospital	8
Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists	8
Cost-effectiveness of clobazam as an adjunctive treatment for refractory epilepsy in China	8
Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study	8
Implementation of pharmacist-led deprescribing in collaborative primary care settings	8
A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS)	8
Association between sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis of randomized active-controlled trials	8
How patient-centredness takes place in pharmacy encounters: a critical common-sense interpretation of video-recorded meetings	8
Perceived importance of tailored education to prevent second victim phenomenon in clinical pharmacy practice: a focus group study with community pharmacists	8
Between what is and what could be: a survey of pharmacists’ practices, attitudes, and beliefs in the provision of mental health care	8
Risk factors for potentially inappropriate medication use in older adults: a cohort study	8
Assessing the cost-effectiveness of replacing antimetabolites with mTOR inhibitors in heart transplant immunosuppression in China: a network meta-analysis-based economic evaluation	8
Drug-related emergency department visits: external validation of an assessment tool in a general emergency department population	7
Determining sensitivity and specificity of risk scores for QTc interval prolongation in hemato-oncology patients prescribed systemic antifungal therapy: a retrospective cross-sectional study	7
Pharmacist-led new medicine service: a real-world cohort study in the Netherlands on drug-related problems, satisfaction, and self-efficacy in cardiovascular patients transitioning to primary care	7
European Society of Clinical Pharmacy: ‘Implementing and scaling sustainable clinical pharmacy’	7
Pharmacovigilance analysis of metabolic and nutritional adverse reactions associated with entecavir and tenofovir using the FDA adverse event reporting system database	7
Investigating the controversy surrounding statin therapy and Achilles tendinopathy using Mendelian randomization analysis	7
Patient and hospital staff perspectives on introducing pharmacist-led medication reviews at an orthopedic ward: a mixed methods pilot study	7
ADHD prescribing: national findings of children and adolescents attending mental health services in Ireland	7
Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries	7
Sex differences among users of NSAIDs and opioids during COVID-19 Pandemic	7
Polypharmacy and medication regimen complexity in transfusion-dependent thalassaemia patients: a cross- sectional study	7
Comparison of the incidence of nausea and vomiting between linezolid and vancomycin using claims database: a retrospective cohort study	7
Barriers and facilitators for the implementation of the CombiConsultation by general practitioners, pharmacists and practice nurses: a qualitative interview study	7
Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study	7
Cost-effectiveness analysis of tislelizumab plus chemotherapy versus standard chemotherapy in first-line treatment for extensive-stage small cell lung cancer: perspectives from the United States and C	7
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database	7
Medication changes and potentially inappropriate prescribing in older patients with significant polypharmacy	7
A qualitative exploration of the enablers and barriers to the provision of outpatient clinics by hospital pharmacists	7
Sex differences in immune-related adverse events with immune checkpoint inhibitors: data mining of the FDA adverse event reporting system	7
Population- and individual-level trajectories of opioid prescription patterns among adults with cerebral palsy: a retrospective cohort study	7
Correction: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis	7
Flight safety risk assessment of self-medication among fighter pilots: a cross-sectional study	6
Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China	6
Community pharmacists’ acceptability of pharmacist-delivered depression screening for older adults: a qualitative study	6
Polypharmacy and medication regimen complexity in older patients with hemophilia or von willebrand disease: the M’HEMORRH-AGE study	6
Consensus on the criteria for patient prioritization in hospital clinical pharmacy services: a Delphi study	6
Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study	6
Levels of serum lipids predict responses to PD-L1 inhibitors as first-line treatment in small cell lung cancer: an observational study	6
Developing a machine learning-based predictive model for the analgesic effectiveness of transdermal fentanyl in cancer patients: an interpretable approach	6
Accuracy of best possible medication histories by pharmacy students: an observational study	6
ESCP Spring Workshop 2023: Advancing clinical pharmacy and care in diabetes and cardiovascular comorbidities—Antwerp, 20–21 April 2023	6
Terms used to describe and define activities undertaken as a result of the medication review process: Do they require standardisation? A systematic review	6
Comparison of clinical effectiveness of conbercept and ranibizumab for treating retinopathy of prematurity: a meta-analysis	6
Short-term outcome of personalized theory-based pharmaceutical care service on the medication administration problems of family caregivers: a pre-post intervention study	6
An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist	6
Application of behavioural theories, models, and frameworks in pharmacy practice research based on published evidence: a scoping review	6
Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-	6
Commentary: how person-centred is pharmaceutical care?	6
Influence of a ward-based pharmacist on the medication quality of geriatric inpatients: a before–after study	6
“A little bit more looking…listening and feeling” A qualitative interview study exploring advanced clinical practice in primary care and community pharmacy	6
Correction: Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ	6
Provision of drug and alcohol services amidst COVID-19 pandemic: a qualitative evaluation on the experiences of service providers	6

Abstracts of the 26th Annual Meeting of ESPACOMP, the International Society for Medication Adherence, Berlin, Germany, 17–19 November 2022	6
Publisher Correction to: Bacillus coagulans TBC169 probiotics for the recovery of intestinal function after gynecological laparoscopic surgery: a randomized, placebo-controlled trial	6
Scope, content and quality of clinical pharmacy practice guidelines: a systematic review	6
Associated factors and safety of the rapidly achieving first therapeutic target of warfarin in hospitalized patients: a retrospective cohort study	6
Developing a theory-based behavior change intervention to improve the prescription of surgical prophylaxis	6
Opioid, sedative, preadmission medication and iatrogenic withdrawal risk in UK adult critically ill patients: a point prevalence study	6
Co-designing psychosis simulated patient scenarios with mental health stakeholders for pharmacy curricula	6
A cohort study of guselkumab in the treatment of psoriasis refractory to previous biologic therapies: effectiveness, safety and adherence	6
Correction: Credentialed pharmacist-led home medicines reviews targeting treatable traits and their impact on health outcomes in people with chronic obstructive pulmonary disease: a pre- and post-inte	6
Author Correction: Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system	6
Development, implementation and evaluation of the digital transformation of renal services in Wales: the journey from local to national	6
Remdesivir for COVID-19 and acute kidney injury: disproportionality analysis of data from the U.S. Food and Drug Administration Adverse Event Reporting System	6
Optimising adherence to secondary prevention medications following acute coronary syndrome utilising telehealth cardiology pharmacist clinics: a matched cohort study	6
Feasibility of individualised patient modelling for continuous vancomycin infusions in outpatient antimicrobial therapy, a retrospective study	6